InvestorsHub Logo
Followers 76
Posts 30351
Boards Moderated 85
Alias Born 03/22/2005

Re: None

Friday, 09/05/2014 11:06:30 PM

Friday, September 05, 2014 11:06:30 PM

Post# of 72
>>> Organovo to Present at the Morgan Stanley Global Healthcare Conference

SAN DIEGO, Sept. 5, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has been invited to present at the Morgan Stanley Global Healthcare Conference, which will be held in New York September 8-10, 2014.

Organovo's Chairman and Chief Executive Officer, Keith Murphy, is scheduled to present at 9:20am on September 8th. The conference is being held at The Grand Hyatt Hotel, New York, NY.

About Organovo Holdings, Inc.

Organovo designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications. The Company is collaborating with pharmaceutical and academic partners to develop human biological disease models in three dimensions. These 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost. In addition to numerous scientific publications, the Company's technology has been featured in The Wall Street Journal, Time Magazine, The Economist, and numerous others. Organovo is changing the shape of medical research and practice. Learn more at


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.